Skip to main content
SpringerLink
Log in

Neuroprotection in Glaucoma

  • Chapter
  • First Online:
Glaucoma

Part of the book series: Essentials in Ophthalmology ((ESSENTIALS))

  • 199 Accesses

Abstract

Neuroprotection refers to a set of therapies for preventing neurons from dying as the result of a disease process. It is thus applicable to many ophthalmic disorders of varied etiology. Examples include diseases due to ischemia (as in central retinal artery occlusion or anterior ischemic optic neuropathy), inflammation (as might be seen with a posterior uveitis or cystoid macular edema), hereditary disorders (such as inherited macular and peripheral retinal degenerations, or Leber’s hereditary optic neuropathy). Neuropro-tection may be particularly valuable for glaucoma, a disorder of complex etiology which results in loss of retinal ganglion cells.

This is a preview of subscription content, log in via an institution to check access.

Access this chapter

Log in via an institution
Chapter
USD 29.95
Price excludes VAT (USA)
  • Available as PDF
  • Read on any device
  • Instant download
  • Own it forever
eBook
USD 169.00
Price excludes VAT (USA)
  • Available as EPUB and PDF
  • Read on any device
  • Instant download
  • Own it forever
Hardcover Book
USD 219.00
Price excludes VAT (USA)
  • Durable hardcover edition
  • Dispatched in 3 to 5 business days
  • Free shipping worldwide - see info

Tax calculation will be finalised at checkout

Purchases are for personal use only

Institutional subscriptions

Preview

Unable to display preview. Download preview PDF.

Unable to display preview. Download preview PDF.

Reference

  1. Agarwal N, Martin E, Krishnamoorthy RR, Landers R, Wen R, Krueger S, Kapin MA, Collier RJ (2002) Levobetaxolol-induced Up-regulation of retinal bFGF and CNTF mRNAs and preservation of retinal function against a photic-induced retinopathy. Exp Eye Res 74: 445–453

    Article  PubMed  CAS  Google Scholar 

  2. Berkelaar M, Clarke DB, Wang YC, Bray GM, Aguayo AJ (1994) Axotomy results in delayed death and apoptosis of retinal ganglion cells in adult rats. J Neurosci 14: 4368–4374

    PubMed  CAS  Google Scholar 

  3. Castillo BJ, del CM, Breakefield XO, Frim DM, Barnstable CJ, Dean DO, Bohn MC (1994) Retinal ganglion cell survival is promoted by genetically modified astrocytes designed to secrete brain-derived neurotrophic factor (BDNF). Brain Res 647: 30–36

    Article  PubMed  CAS  Google Scholar 

  4. Cellerino A, Kohler K (1997) Brain-derived neu-rotrophic factor/neurotrophin-4 receptor TrkB is localized on ganglion cells and dopaminergic amacrine cells in the vertebrate retina. J Comp Neurol 386: 149–160

    Article  PubMed  CAS  Google Scholar 

  5. Chao HM, Chidlow G, Melena J, Wood JP, Osborne NN (2000) An investigation into the potential mechanisms underlying the neuroprotective effect of clonidine in the retina. Brain Res 877: 47–57

    Article  PubMed  CAS  Google Scholar 

  6. Chaudhary P, Ahmed F, Sharma SC (1998) MK801-a neuroprotectant in rat hypertensive eyes. Brain Res 792: 154–158

    Article  PubMed  CAS  Google Scholar 

  7. C hidlow G, Melena J, Osborne NN (2000) Betax-olol, a beta(1)-adrenoceptor antagonist, reduces Na(+) influx into cortical synaptosomes by direct interaction with Na(+) channels: comparison with other beta-adrenoceptor antagonists. Br J Pharmacol 130: 759–766

    Article  PubMed  CAS  Google Scholar 

  8. DiPolo A, Aigner LJ, Dunn RJ, Bray GM, Aguayo AJ (1998) Prolonged delivery of brain-derived neu-rotrophic factor by adenovirus-infected Muller cells temporarily rescues injured retinal ganglion cells. Proc Natl Acad Sci USA 95: 3978–3983

    Article  CAS  Google Scholar 

  9. Gao H, Qiao X, Cantor LB, Wu Dunn D (2002) Up-regulation of brain-derived neurotrophic factor expression by brimonidine in rat retinal ganglion cells. Arch Ophthalmol 120: 797–803

    Article  PubMed  CAS  Google Scholar 

  10. Greenlund LJ, Deckwerth TL, Johnson EM (1995) Superoxide dismutase delays neuronal apoptosis: a role for reactive oxygen species in programmed neuronal death. Neuron 14: 303–315

    Article  PubMed  CAS  Google Scholar 

  11. Hare W, WoldeMussie E, Lai R, Ton H, Ruiz G, Feldmann B, Wijono M, Chun T, Wheeler L (2001) Efficacy and safety of memantine,an NMDA-type open-channel blocker, for reduction of retinal injury associated with experimental glaucoma in rat and monkey. Surv Ophthalmol 45[Suppl 3]: S284–289; discussion S295–286

    Article  PubMed  Google Scholar 

  12. Hockenbery DM, Oltvai ZN, Yin XM, Milliman CL, Korsmeyer SJ (1993) Bcl-2 functions in an antioxidant pathway to prevent apoptosis. Cell 75: 241–251

    Article  PubMed  CAS  Google Scholar 

  13. Isenmann S, Klocker N, Gravel C, Bahr M (1998) Short communication: protection of axotomized retinal ganglion cells by adenovirally delivered BDNF in vivo. Eur J Neurosci 10: 2751–2756

    Article  PubMed  CAS  Google Scholar 

  14. Kane DJ, Sarafian TA, Anton R, Hahn H, Gralla EB, Valentine JS, Ord T, Bredesen DE (1993) Bcl-2 inhibition of neural death: decreased generation of reactive oxygen species. Science 262: 1274–1277

    Article  PubMed  CAS  Google Scholar 

  15. Kashiwagi K, Iizuka Y, Tsukahara S (2002) Neuro-protective effects of nipradilol on purified cultured retinal ganglion cells. J Glaucoma 11: 231–238

    Article  PubMed  Google Scholar 

  16. Kent AR, Nussdorf JD, David R, Tyson F, Small D, Fellows D (2001) Vitreous concentration of topically applied brimonidine tartrate 0.2%. Ophthalmology 108: 784–787

    Article  PubMed  CAS  Google Scholar 

  17. Kido N, Tanihara H, Honjo M, Inatani M, Tatsuno T, Nakayama C, Honda Y (2000) Neuroprotective effects of brain-derived neurotrophic factor in eyes with NMDA-induced neuronal death. Brain Res 884: 59–67

    Article  PubMed  CAS  Google Scholar 

  18. Ko ML, Hu DN, Ritch R, Sharma SC (2000) The combined effect of brain-derived neurotrophic factor and a free radical scavenger in experimental glaucoma. Invest Ophthalmol Vis Sci 41: 2967– 2971

    PubMed  CAS  Google Scholar 

  19. Lagreze WA, Knorle R, Bach M, Feuerstein TJ (1998) Memantine is neuroprotective in a rat model of pressure-induced retinal ischemia. Invest Ophthalmol Vis Sci 39: 1063–1066

    PubMed  CAS  Google Scholar 

  20. Lam TT, Siew E, Chu R, Tso MO (1997) Ameliorative effect of MK-801 on retinal ischemia. J Ocul Pharmacol Ther 13: 129–137

    Article  PubMed  CAS  Google Scholar 

  21. Levin LA, Clark JA, Johns LK (1996) Effect of lipid peroxidation inhibition on retinal ganglion cell death. Invest Ophthalmol Vis Sci 37: 2744–2749

    CAS  Google Scholar 

  22. Levin LA, Louhab A (1996) Apoptosis of retinal ganglion cells in anterior ischemic optic neuropathy. Arch Ophthalmol 114: 488–491

    Article  PubMed  CAS  Google Scholar 

  23. Lipton SA (2003) Possible role for memantine in protecting retinal ganglion cells from glaucomatous damage. Surv Ophthalmol 48[Suppl 11]: S38– 46

    Article  PubMed  Google Scholar 

  24. Liu B, Neufeld AH (2000) Expression of nitric ox-ide synthase-2 (NOS-2) in reactive astrocytes of the human glaucomatous optic nerve head. Glia 30: 178–186

    Article  PubMed  CAS  Google Scholar 

  25. Liu B, Neufeld AH (2001) Nitric oxide synthase-2 in human optic nerve head astrocytes induced by elevated pressure in vitro. Arch Ophthalmol 119: 240–245

    PubMed  CAS  Google Scholar 

  26. Maffei L, Carmignoto G, Perry VH, Candeo P, Fer-rari G (1990) Schwann cells promote the survival of rat retinal ganglion cells after optic nerve section. Proc Natl Acad Sci USA 87: 1855–1859

    Article  PubMed  CAS  Google Scholar 

  27. Mansour-Robaey S, Clarke DB, Wang YC, Bray GM, Aguayo AJ (1994) Effects of ocular injury and administration of brain-derived neurotrophic factor on survival and regrowth of axotomized retinal ganglion cells. Proc Natl Acad Sci USA 91: 1632–1636

    Article  PubMed  CAS  Google Scholar 

  28. Melena J, Stanton D, Osborne NN (2001) Comparative effects of antiglaucoma drugs on voltage-dependent calcium channels. Graefes Arch Clin Exp Ophthalmol 239: 522–530

    Article  PubMed  CAS  Google Scholar 

  29. Melena J, Wood JP, Osborne NN (1999) Betaxolol, a beta1-adrenoceptor antagonist, has an affinity for L-type Ca2+ channels. Eur J Pharmacol 378: 317–322

    Article  PubMed  CAS  Google Scholar 

  30. Mey J, Thanos S (1993) Intravitreal injections of neurotrophic factors support the survival of axotomized retinal ganglion cells in adult rats in vivo. Brain Res 602: 304–317

    Article  PubMed  CAS  Google Scholar 

  31. Moalem G, Gdalyahu A, Shani Y, Otten U, Lazarovici P, Cohen IR, Schwartz M (2000) Production of neurotrophins by activated T cells: implications for neuroprotective autoimmunity. J Autoimmun 15: 331–345

    Article  PubMed  CAS  Google Scholar 

  32. Nakazawa T, Tomita H, Yamaguchi K, Sato Y, Shimura M, Kuwahara S, Tamai M (2002) Neuro-protective effect of nipradilol on axotomized rat retinal ganglion cells. Curr Eye Res 24: 114–122

    Article  PubMed  Google Scholar 

  33. Neufeld AH, Das S, Vora S, Gachie E, Kawai S, Manning PT, Connor JR (2002) A prodrug of a selective inhibitor of inducible nitric oxide synthase is neuroprotective in the rat model of glaucoma. J Glaucoma 11: 221–225

    Article  PubMed  Google Scholar 

  34. Neufeld AH, Sawada A, Becker B (1999) Inhibition of nitric-oxide synthase 2 by aminoguanidine provides neuroprotection of retinal ganglion cells in a rat model of chronic glaucoma. Proc Natl Acad Sci USA 96: 9944–9948

    Article  PubMed  CAS  Google Scholar 

  35. Osborne NN, Cazevieille C, Carvalho AL, Larsen AK, DeSantis L (1997) In vivo and in vitro experiments show that betaxolol is a retinal neuropro-tective agent. Brain Res 751: 113–123

    Article  PubMed  CAS  Google Scholar 

  36. Parsons CG, Danysz W, Quack G (1999) Meman-tine is a clinically well tolerated N-methyl-D-as-partate (NMDA) receptor antagonist-a review of preclinical data. Neuropharmacology 38: 735–767

    Article  PubMed  CAS  Google Scholar 

  37. Perez MT, Caminos E (1995) Expression of brain-derived neurotrophic factor and of its functional receptor in neonatal and adult rat retina. Neu-rosci Lett 183: 96–99

    Article  PubMed  CAS  Google Scholar 

  38. Quigley HA, Nickells RW, Kerrigan LA, Pease ME, Thibault DJ, Zack DJ (1995) Retinal ganglion cell death in experimental glaucoma and after axoto-my occurs by apoptosis. Invest Ophthalmol Vis Sci 36: 774–786

    PubMed  CAS  Google Scholar 

  39. Reisberg B, Doody R, Stoffler A, Schmitt F, Ferris S, Mobius HJ (2003) Memantine in moderate-to-severe Alzheimer’s disease. N Engl J Med 348: 1333–1341

    Article  PubMed  CAS  Google Scholar 

  40. Schori H, Kipnis J, Yoles E, WoldeMussie E, Ruiz G, Wheeler LA, Schwartz M (2001) Vaccination for protection of retinal ganglion cells against death from glutamate cytotoxicity and ocular hyper-tension: implications for glaucoma. Proc Natl Acad Sci USA 98: 3398–3403

    Article  PubMed  CAS  Google Scholar 

  41. Schwartz M (2001) Physiological approaches to neuroprotection. boosting of protective autoimmunity. Surv Ophthalmol 45[Suppl 3]:S256–260; discussion S273–256

    Article  PubMed  Google Scholar 

  42. Shareef S, Sawada A, Neufeld AH (1999) Isoforms of nitric oxide synthase in the optic nerves of rat eyes with chronic moderately elevated intraocular pressure. Invest Ophthalmol Vis Sci 40: 2884–2891

    PubMed  CAS  Google Scholar 

  43. Tappel AL (1973) Lipid peroxidation damage to cell components. Fed Proc. 32: 1870–1874

    PubMed  CAS  Google Scholar 

  44. Tatton WG, Chalmers-Redman RM, Tatton NA (2001) Apoptosis and anti-apoptosis signalling in glaucomatous retinopathy. Eur J Ophthalmol 11[Suppl 2]: S12–22

    PubMed  Google Scholar 

  45. Vidal-Sanz M, Lafuente MP, Mayor S, de Imperial JM, Villegas-Perez MP (2001) Retinal ganglion cell death induced by retinal ischemia. neuropro-tective effects of two alpha-2 agonists. Surv Oph-thalmol 45: S261–267

    Article  Google Scholar 

  46. Wen R, Cheng T, Li Y, Cao W, Steinberg RH (1996) Alpha 2-adrenergic agonists induce basic fibrob-last growth factor expression in photoreceptors in vivo and ameliorate light damage. J Neurosci 16: 5986–5992

    PubMed  CAS  Google Scholar 

  47. Wheeler LA, Gil DW, WoldeMussie E (2001) Role of alpha-2 adrenergic receptors in neuroprotection and glaucoma. Surv Ophthalmol 45[Suppl 3]: S290–294; discussion S295–296

    Article  PubMed  Google Scholar 

  48. WoldeMussie E, Ruiz G, Wijono M, Wheeler LA (2001) Neuroprotection of retinal ganglion cells by brimonidine in rats with laser-induced chronic ocular hypertension. Invest Ophthalmol Vis Sci 42: 2849–2855

    PubMed  CAS  Google Scholar 

  49. Wood JP, DeSantis L, Chao HM, Osborne NN (2001) Topically applied betaxolol attenuates is-chaemia-induced effects to the rat retina and stimulates BDNF mRNA. Exp Eye Res 72: 79–86

    Article  PubMed  CAS  Google Scholar 

  50. Wood JP, Schmidt KG, Melena J, Chidlow G, Allmeier H, Osborne NN (2003) The beta-adrenoceptor antagonists metipranolol and tim-olol are retinal neuroprotectants: comparison with betaxolol. Exp Eye Res 76: 505–516

    Article  PubMed  CAS  Google Scholar 

  51. Yoles E, Wheeler LA, Schwartz M (1999) Alpha2-adrenoreceptor agonists are neuroprotective in a rat model of optic nerve degeneration. Invest Ophthalmol Vis Sci 40: 65–73

    PubMed  CAS  Google Scholar 

  52. Zhang J, Wu SM, Gross RL (2003) Effects of beta-adrenergic blockers on glutamate-induced calcium signals in adult mouse retinal ganglion cells. Brain Res 959: 111–119

    Article  PubMed  CAS  Google Scholar 

Download references

Authors
  1. Leonard A. Levin
    View author publications

    You can also search for this author in PubMed Google Scholar

Rights and permissions

Reprints and permissions

Copyright information

© 2004 Springer-Verlag Berlin Heidelberg

About this chapter

Cite this chapter

Levin, L.A. (2004). Neuroprotection in Glaucoma. In: Glaucoma. Essentials in Ophthalmology. Springer, Berlin, Heidelberg. https://doi.org/10.1007/978-3-642-18633-2_2

Download citation

  • DOI: https://doi.org/10.1007/978-3-642-18633-2_2

  • Published:

  • Publisher Name: Springer, Berlin, Heidelberg

  • Print ISBN: 978-3-540-40608-2

  • Online ISBN: 978-3-642-18633-2

  • eBook Packages: Springer Book Archive

Publish with us

Policies and ethics

Search

Navigation